MedTech Business - June 27, 2019
Dignitana receives FDA clearance
The United States Food and Drug Administration has cleared DigniCap Delta for use by U.S. health care providers. The new device is the fourth generation of The DigniCap Scalp Cooling System and is indicated to prevent chemotherapy-induced hair loss in patients with solid tumors. European installations of DigniCap Delta began last month after the device […]
Legal Advice article - May 14, 2019
Dignitana efforts prompt landmark legislation
The company announces that HB3984, the bill providing coverage for scalp cooling that the company initiated in February with Texas State legislators, was passed in the Texas House of Representatives on Friday. The Bill now moves to the Senate where it will be introduced by Sen. Angela Paxton. Once passed in the Senate, the Bill […]
In a new job - August 4, 2017
Changes to the Board of Directors at Dignitana
Dignitana announces that Board Member Magnus Nilsson will resign from his position due to changes in his current professional responsibilities. As CEO of Xvivo Perfusion AB, Magnus Nilsson will move to the United States to develop Xvivo’s U.S. subsidiary during the coming period. Thereby he will spend most of his time abroad. Magnus Nilsson has […]
MedTech Business - July 4, 2017
FDA expands Dignicap clearance in the US
Dignitana has received clearance from the U.S. Food and Drug Administration (FDA) to expand use of its medical device to patients in the United States receiving chemotherapy for solid tumor cancers. Originally cleared in December 2015 by the FDA as the first scalp cooling device for use in women with breast cancer, the clinically-tested automated scalp cooling […]
Collaboration - June 27, 2017
International scalp cooling collaboration launched
Dignitana is partnering with the organization known as CHILL, Cancer-related Hair Loss, International Leadership and Linkage, which was launched this past weekend at the 2017 Annual Meeting of the Multinational Association of Supportive Care in Cancer (MASCC), held in Washington, D.C. Led by six globally-recognized experts in cancer care, CHILL is an initiative designed to […]
Agreement - June 12, 2017
Dignitana partners with Piedmont Cancer Institute
Swedish Dignitana has announced that their medical device, the DigniCap scalp cooling system, will be offered at Piedmont Cancer Institute in Georgia. FDA-cleared in 2015, the DigniCap Scalp Cooling System will be available this summer at Piedmont’s center in Atlanta, with installation at other Piedmont locations to follow. The device features a patented tight-fitting silicone […]
